The specific activity of PLK1 was equivalent to 42 nmol/min/mg as per Activity Assay Protocol and was equivalent to 17 nmol/min/mg as per radiometric assay.
Source
Spodoptera frugiperda, Sf 9 (baculovirus)-derived human PLK1 protein
This product is stable at ≤ ‑70 °C for up to 1 year from the date of receipt. For optimal storage, aliquot into smaller quantities after centrifugation and store at recommended temperature. Avoid repeated freeze-thaw cycles.
Buffer
Supplied in 50 mM Sodium Phosphate (pH 7.0), 300 mM NaCl, 150 mM Imidazole, 0.1 mM PMSF, 0.25 mM DTT, and 25% Glycerol.
Purity
>90%, by SDS-PAGE under reducing conditions and visualized by Colloidal Coomassie® Blue stain at 5 μg per lane.
Assay Procedure
Active
Kinase - Active PLK1 (0.1 μg/μL) diluted with Kinase Dilution Buffer IX and
assayed as outlined in Sample Activity Plot. Note: These are
suggested working dilutions and it is recommended that the researcher perform a
serial dilution of active PLK1 for optimal results.
Kinase Assay Buffer III (5X) - 200 mM Tris-HCl, pH 7.4, 100 mM
MgCl2, and 0.5 mg/mL BSA. Add fresh DTT prior to use to
a final concentration of 250 μM.
Kinase Dilution Buffer IX (1X) - Kinase Assay Buffer III diluted at a 1:4 ratio (5X dilution) with cold distilled or deionized water. Add fresh DTT to the aliquot prior to use to
a final concentration of 50 μM.
ADP-Glo™ Kinase Assay Kit
- 10 mM ATP Solution, 10 mM ADP Solution, ADP-Glo™ Reagent, and Kinase
Detection Reagent.
Substrate - PLKtide peptide substrate was diluted in 20 mM Tris-HCl, pH 7.5 solution to a final concentration
of 1 mg/mL.
Thaw the
Active PLK1, Kinase Assay Buffer III (5X), and Substrate on ice. Prepare a 15
μL enzyme dilution at the desired concentration, with Kinase Dilution Buffer IX (1X), in a pre-chilled 96-well plate.
Prepare a Substrate/ATP
mixture as follows (25 μM example): a. 10 mM ATP Solution: 1
μL b. Kinase Assay Buffer III (5X): 79 μL c. Substrate at 1
mg/mL: 80 μL
Transfer the following reaction components prepared in Step 2
to a 384-well opaque plate, bringing the reaction volume up to 5
μL: a. 3 μL of diluted Active PLK1 b. 2 μL of Substrate/ATP mix as
prepared in Step 2. This initiates the reaction.
Set
up the blank control as outlined in Step 2, excluding the addition of the
kinase. Replace the kinase with an equal volume of Kinase Dilution Buffer IX (1X).
Incubate at ambient temperature for 40
minutes.
After the 40 minute incubation period, terminate
the reaction and deplete the remaining ATP by adding 5 μL of ADP-Glo™ Reagent.
Spin down and shake the 384-well plate. Then incubate the reaction mixture for
another 40 minutes at ambient temperature.
Add 10 μL of
the Kinase Detection Reagent to the 384-well plate and incubate the reaction
mixture for another 30 minutes at ambient temperature.
Read the 384-well reaction plate using the Luminescence Module
Protocol on a GloMax®-Multi Microplate Multimode Reader.
Determine the corrected activity (RLU) by removing the blank control
value (see Step 4) for each sample and calculate the kinase specific activity
as outlined below.
Calculation of
Specific Activity of ADP (RLU/pmol) From ADP standard curve,
determine RLU/pmol of ADP
Kinase Specific Activity
(SA) (pmol/min/μg or nmol/min/mg) Corrected RLU from
reaction / [(SA of ADP in RLU/pmol) x (Reaction time in min) x (Enzyme
amount in μg or mg)]
Notes
This product is produced by and ships from R&D Systems, Inc., a Bio-Techne brand.
Alternate Names for Recombinant Human Active PLK1 Protein, CF
cell cycle regulated protein kinase
EC 2.7.11
EC 2.7.11.21
PLK
PLK1
PLK-1
polo (Drosophia)-like kinase
polo like kinase
polo-like kinase 1polo-like kinase (Drosophila)
Serine/threonine-protein kinase 13
serine/threonine-protein kinase PLK1
STPK13
Background
PLK1 is a member of the Polo-Like Kinase family that localizes to centrosomes or spindle pole bodies and undergoes dramatic subcellular relocation during the cell cycle. Deregulated activities of PLKs often result in abnormalities in centrosome duplication, maturation, and/or microtubule dynamics (1). PLKs also regulate the function of the Golgi complex. Deregulated expression of human PLK1 is strongly correlated with the development of many types of malignancies, and ectopic expression of PLK1 dominant negative protein leads to rapid cell death (2).
Nigg, E.A. et al. (1996) Exp. Cell Res. 229:174.
Dai, W. et al. (2003) Prog. Cell Cycle Res. 5:327.
The concentration calculator allows you to quickly calculate the volume, mass or concentration of your vial. Simply enter your mass, volume, or concentration values for your reagent and the calculator will determine the rest.
=
÷
Review this Product
Be the first to review our Recombinant Human Active PLK1 Protein, CF and receive a gift card or discount.